Director, Life Science and Senior Investment Manager
Bayern KapitalCheck size: €250K-€50M across stages, as published in Bayern Kapital's official investment criteria.
Dr. Nathalie Weitemeyer invests or supports investment decisions through Bayern Kapital's published strategy: Co-invest as a long-term anchor from pre-seed through growth in scalable high-tech and deep-tech companies with a registered office or operating site in Bavaria.
Complementary expert teams, scalable B2B models, private co-investors and defensible innovation rooted in Bavaria.
The published criteria require high-tech or deep-tech, scalable B2B economics, a Bavarian presence and at least one additional new private investor at entry.
Show the Bavarian presence, technical moat, scalable B2B model, complementary team, private co-investor and stage-appropriate use of capital.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Dr. Nathalie Weitemeyer is a current Director, Life Science and Senior Investment Manager at Bayern Kapital, according to the firm's official roster. No education, prior employment or personal deal claims are inferred where the firm does not publish them.